“…Dynamic contrast‐enhanced computed tomography has been used in dogs, and several proof‐of‐principle studies have assessed normal tissues and tumors, and compared DCECT to 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography. 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 Two studies specifically reported DCECT in nasal tumors but did not find correlation with histogenesis or survival. 33 , 39 Our objectives were (a) to assess baseline perfusion parameters in dogs with nasal tumors based on histopathological type, (b) to characterize changes in perfusion parameters with changes in tumor volume after the start of RT, and (c) to evaluate if a correlation existed of either objective 1 or objective 2 with survival.…”